Comprehensive analysis of alternative splicing across tumors from 8,705 patients (2018)
Source: Cancer Cell. Unidade: FMRP
Subjects: NEOPLASIAS, IMUNOTERAPIA, ANTÍGENOS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAHLES, André et al. Comprehensive analysis of alternative splicing across tumors from 8,705 patients. Cancer Cell, v. 34, n. 2, p. 211–224, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ccell.2018.07.001. Acesso em: 31 out. 2024.APA
Kahles, A., Lehmann, K. -V., Toussaint, N. C., Huser, M., Stark, S. G., Sachsenberg, T., et al. (2018). Comprehensive analysis of alternative splicing across tumors from 8,705 patients. Cancer Cell, 34( 2), 211–224. doi:10.1016/j.ccell.2018.07.001NLM
Kahles A, Lehmann K-V, Toussaint NC, Huser M, Stark SG, Sachsenberg T, Stegle O, Kohlbacher O, Sander C, Ratsch G, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Comprehensive analysis of alternative splicing across tumors from 8,705 patients [Internet]. Cancer Cell. 2018 ; 34( 2): 211–224.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ccell.2018.07.001Vancouver
Kahles A, Lehmann K-V, Toussaint NC, Huser M, Stark SG, Sachsenberg T, Stegle O, Kohlbacher O, Sander C, Ratsch G, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Comprehensive analysis of alternative splicing across tumors from 8,705 patients [Internet]. Cancer Cell. 2018 ; 34( 2): 211–224.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ccell.2018.07.001
